Ignite Creation Date:
2024-05-06 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03643549
Status:
RECRUITING
Last Update Posted:
2024-02-29
First Post:
2018-08-21
Brief Title:
Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter BORTEM-17
Sponsor:
Haukeland University Hospital
Organization:
Haukeland University Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-08-21
First Submit QC Date:
August 21 2018
Study First Post Date:
2018-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-27
Last Update Post Date:
2024-02-29
Last Update Post Date Type:
ACTUAL